| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/27/2023 | 15.68% | Truist Securities | $22 → $18 | Maintains | Buy |
| 11/22/2023 | 22.11% | BTIG | $23 → $19 | Maintains | Buy |
| 10/26/2023 | 14.07% | Stifel | $20 → $17.75 | Maintains | Buy |
| 10/19/2023 | -3.6% | Mizuho | → $15 | Initiates Coverage On | → Neutral |
| 10/12/2023 | -16.45% | Keybanc | → $13 | Downgrades | Sector Weight → Underweight |
| 10/10/2023 | -3.6% | B of A Securities | $20 → $15 | Downgrades | Neutral → Underperform |
| 09/15/2023 | 28.53% | Stifel | $21 → $20 | Maintains | Buy |
| 07/07/2023 | 34.96% | Stifel | $21.5 → $21 | Maintains | Buy |
| 07/06/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
| 06/14/2023 | 47.81% | Exane BNP Paribas | → $23 | Initiates Coverage On | → Outperform |
| 04/27/2023 | 38.17% | Stifel | $22.5 → $21.5 | Maintains | Buy |
| 04/12/2023 | 28.53% | Scotiabank | $22 → $20 | Downgrades | Sector Outperform → Sector Perform |
| 01/09/2023 | 34.96% | Raymond James | $23 → $21 | Downgrades | Strong Buy → Outperform |
| 12/19/2022 | 47.81% | Raymond James | $24 → $23 | Maintains | Strong Buy |
| 12/14/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 11/14/2022 | 34.96% | B of A Securities | $22 → $21 | Downgrades | Buy → Neutral |
| 09/22/2022 | 47.81% | Baird | → $23 | Initiates Coverage On | → Outperform |
| 09/14/2022 | 54.24% | Raymond James | → $24 | Initiates Coverage On | → Strong Buy |
| 09/13/2022 | 47.81% | BTIG | $27 → $23 | Maintains | Buy |
| 06/30/2022 | 47.81% | Jefferies | $25 → $23 | Maintains | Buy |
| 06/28/2022 | 47.81% | Keybanc | $27 → $23 | Maintains | Overweight |
| 09/08/2021 | 92.8% | Wells Fargo | $26 → $30 | Maintains | Overweight |
| 07/15/2021 | 73.52% | Keybanc | $23 → $27 | Maintains | Overweight |
| 07/09/2021 | 67.1% | Wells Fargo | $20.5 → $26 | Maintains | Overweight |
| 06/15/2021 | 86.38% | Wolfe Research | → $29 | Initiates Coverage On | → Outperform |
| 01/07/2021 | 34.96% | ScotiaBank | → $21 | Initiates Coverage On | → Outperform |
| 10/21/2020 | 47.81% | Berenberg | → $23 | Initiates Coverage On | → Buy |
| 10/16/2020 | 34.96% | Keybanc | → $21 | Initiates Coverage On | → Overweight |
| 09/08/2020 | 44.6% | Stifel | → $22.5 | Initiates Coverage On | → Buy |
| 09/08/2020 | 34.96% | BTIG | → $21 | Initiates Coverage On | → Buy |
| 09/08/2020 | 47.81% | Truist Securities | → $23 | Initiates Coverage On | → Buy |
| 09/08/2020 | 18.89% | Citigroup | → $18.5 | Initiates Coverage On | → Neutral |
| 09/08/2020 | 31.75% | Wells Fargo | → $20.5 | Initiates Coverage On | → Overweight |
| 09/08/2020 | 41.39% | Jefferies | → $22 | Initiates Coverage On | → Buy |
What is the target price for Netstreit (NTST)?
The latest price target for Netstreit (NYSE: NTST) was reported by Truist Securities on November 27, 2023. The analyst firm set a price target for $18.00 expecting NTST to rise to within 12 months (a possible 15.68% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Netstreit (NTST)?
The latest analyst rating for Netstreit (NYSE: NTST) was provided by Truist Securities, and Netstreit maintained their buy rating.
When is the next analyst rating going to be posted or updated for Netstreit (NTST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Netstreit, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Netstreit was filed on November 27, 2023 so you should expect the next rating to be made available sometime around November 27, 2024.
Is the Analyst Rating Netstreit (NTST) correct?
While ratings are subjective and will change, the latest Netstreit (NTST) rating was a maintained with a price target of $22.00 to $18.00. The current price Netstreit (NTST) is trading at is $15.56, which is out of the analyst's predicted range.